Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-15 4:27 pm Sale |
2025-01-08 | 13G | Poseida Therapeutics, Inc. PSTX |
Malin Life Sciences Holdings Limited | 0 0.000% |
-9,188,125 (Position Closed) |
Filing History |
| 2022-09-07 11:37 am Sale |
2022-08-31 | 13G | Immunocore Holdings plc IMCR |
Malin Life Sciences Holdings Limited | 2,109,425 4.560% |
-280,554 (-11.74%) |
Filing History |
| 2022-02-10 4:55 pm Purchase |
2021-12-31 | 13G | Immunocore Holdings plc IMCR |
Malin Life Sciences Holdings Limited | 2,389,979 5.450% |
30,554 (+1.29%) |
Filing History |
| 2021-10-15 1:17 pm Purchase |
2021-10-15 | 13G | Immunocore Holdings plc IMCR |
Malin Life Sciences Holdings Limited | 2,359,425 5.390% |
2,359,425 (New Position) |
Filing History |
| 2021-02-03 06:15 am Purchase |
2020-07-14 | 13G | Poseida Therapeutics, Inc. PSTX |
Malin Life Sciences Holdings Limited | 9,188,125 14.900% |
9,188,125 (New Position) |
Filing History |